Literature DB >> 15128427

Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes?

P Felderbauer1, P R Ritter, D Mattern, F Schmitz, K Bulut, N Ansorge, A Schmitt-Graeff, W E Schmidt, J E Baier.   

Abstract

We report the case of a patient with acquired pure megakaryocytic aplasia. Until today, less than 20 cases of acquired pure megakaryocytic aplasia have been reported and the disease aetiology still seems to be unclear. This report summarizes the published data concerning possible aetiologies, treatment options and outcome of patients with acquired pure megakaryocytic aplasia. Furthermore, this case report presents an example for a possible disease progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128427     DOI: 10.1111/j.1600-0609.2004.00241.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

Review 1.  [Adult autoimmune thrombocytopenia: diagnosis and treatment].

Authors:  Klaus Lechner; Ansgar Weltermann; Ingrid Pabinger
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

Review 2.  [Normal bone marrow and common reactive alterations].

Authors:  A Tzankov; S Dirnhofer; C Beham-Schmid
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

3.  Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin.

Authors:  Pimjai Niparuck; Vichai Atichartakarn; Suporn Chuncharunee
Journal:  Int J Hematol       Date:  2008-07-15       Impact factor: 2.490

4.  [Acquired amegacaryocytic thrombocytopenic purpura hiding acute myeloid leukemia].

Authors:  Hicham Eddou; Ali Zinebi; Abdelaziz Khalloufi; Mohammed Sina; Mehdi Mahtat; Kamal Doghmi; Mohammed Mikdame; Mohammed Karim Moudden; Mohammed El Baaj
Journal:  Pan Afr Med J       Date:  2017-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.